Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation Article Swipe
Ko Ko Maung
,
Benny J. Chen
,
Ian Barak
,
Zhiguo Li
,
David A. Rizzieri
,
Cristina Gasparetto
,
Keith M. Sullivan
,
Gwynn D. Long
,
Ashley Morris Engemann
,
Barbara Waters‐Pick
,
Krista Rowe Nichols
,
Richard D. Lopez
,
Yubin Kang
,
Stefanie Sarantopoulos
,
Anthony D. Sung
,
Nelson J. Chao
,
Mitchell E. Horwitz
·
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.1038/s41409-020-0991-5
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.1038/s41409-020-0991-5
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1038/s41409-020-0991-5
- OA Status
- green
- Cited By
- 27
- References
- 16
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3040015203
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3040015203Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1038/s41409-020-0991-5Digital Object Identifier
- Title
-
Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantationWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2020Year of publication
- Publication date
-
2020-07-05Full publication date if available
- Authors
-
Ko Ko Maung, Benny J. Chen, Ian Barak, Zhiguo Li, David A. Rizzieri, Cristina Gasparetto, Keith M. Sullivan, Gwynn D. Long, Ashley Morris Engemann, Barbara Waters‐Pick, Krista Rowe Nichols, Richard D. Lopez, Yubin Kang, Stefanie Sarantopoulos, Anthony D. Sung, Nelson J. Chao, Mitchell E. HorwitzList of authors in order
- Landing page
-
https://doi.org/10.1038/s41409-020-0991-5Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.ncbi.nlm.nih.gov/pmc/articles/10805111Direct OA link when available
- Concepts
-
Medicine, Donor lymphocyte infusion, Transplantation, Hematopoietic stem cell transplantation, Stem cell, Graft-versus-host disease, Lymphocyte, Gastroenterology, Adverse effect, Internal medicine, Immunology, Genetics, BiologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
27Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 2, 2024: 6, 2023: 9, 2022: 5, 2021: 4Per-year citation counts (last 5 years)
- References (count)
-
16Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3040015203 |
|---|---|
| doi | https://doi.org/10.1038/s41409-020-0991-5 |
| ids.doi | https://doi.org/10.1038/s41409-020-0991-5 |
| ids.mag | 3040015203 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/32624583 |
| ids.openalex | https://openalex.org/W3040015203 |
| fwci | 2.98171593 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000328 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Adult |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D006086 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Graft vs Host Disease |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D018380 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Hematopoietic Stem Cell Transplantation |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D006801 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Humans |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D017710 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Lymphocyte Transfusion |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D009364 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Neoplasm Recurrence, Local |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D013601 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | T-Lymphocytes |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D000328 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Adult |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D006086 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Graft vs Host Disease |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D018380 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Hematopoietic Stem Cell Transplantation |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D006801 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Humans |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D017710 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Lymphocyte Transfusion |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D009364 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Neoplasm Recurrence, Local |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D013601 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | T-Lymphocytes |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D000328 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Adult |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D006086 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Graft vs Host Disease |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D018380 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Hematopoietic Stem Cell Transplantation |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D006801 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Humans |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D017710 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Lymphocyte Transfusion |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D009364 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Neoplasm Recurrence, Local |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D013601 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | T-Lymphocytes |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D000328 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Adult |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D006086 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Graft vs Host Disease |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D018380 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Hematopoietic Stem Cell Transplantation |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D006801 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Humans |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D017710 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Lymphocyte Transfusion |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D009364 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Neoplasm Recurrence, Local |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D013601 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | T-Lymphocytes |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D000328 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Adult |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D006086 |
| mesh[29].is_major_topic | True |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Graft vs Host Disease |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D018380 |
| mesh[30].is_major_topic | True |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Hematopoietic Stem Cell Transplantation |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D006801 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Humans |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D017710 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Lymphocyte Transfusion |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D009364 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Neoplasm Recurrence, Local |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D013601 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | T-Lymphocytes |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D000328 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Adult |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D006086 |
| mesh[36].is_major_topic | True |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Graft vs Host Disease |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D018380 |
| mesh[37].is_major_topic | True |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Hematopoietic Stem Cell Transplantation |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D006801 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Humans |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D017710 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Lymphocyte Transfusion |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D009364 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Neoplasm Recurrence, Local |
| mesh[41].qualifier_ui | |
| mesh[41].descriptor_ui | D013601 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | |
| mesh[41].descriptor_name | T-Lymphocytes |
| type | article |
| title | Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation |
| biblio.issue | 1 |
| biblio.volume | 56 |
| biblio.last_page | 143 |
| biblio.first_page | 137 |
| topics[0].id | https://openalex.org/T10345 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2720 |
| topics[0].subfield.display_name | Hematology |
| topics[0].display_name | Hematopoietic Stem Cell Transplantation |
| topics[1].id | https://openalex.org/T11020 |
| topics[1].field.id | https://openalex.org/fields/24 |
| topics[1].field.display_name | Immunology and Microbiology |
| topics[1].score | 0.9991999864578247 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2403 |
| topics[1].subfield.display_name | Immunology |
| topics[1].display_name | Immune Cell Function and Interaction |
| topics[2].id | https://openalex.org/T10031 |
| topics[2].field.id | https://openalex.org/fields/24 |
| topics[2].field.display_name | Immunology and Microbiology |
| topics[2].score | 0.9991000294685364 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2403 |
| topics[2].subfield.display_name | Immunology |
| topics[2].display_name | T-cell and B-cell Immunology |
| is_xpac | False |
| apc_list.value | 3580 |
| apc_list.currency | EUR |
| apc_list.value_usd | 4480 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9186566472053528 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2779695342 |
| concepts[1].level | 4 |
| concepts[1].score | 0.7625124454498291 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q5296800 |
| concepts[1].display_name | Donor lymphocyte infusion |
| concepts[2].id | https://openalex.org/C2911091166 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5919383764266968 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q106419912 |
| concepts[2].display_name | Transplantation |
| concepts[3].id | https://openalex.org/C2777408962 |
| concepts[3].level | 3 |
| concepts[3].score | 0.5686824917793274 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1128050 |
| concepts[3].display_name | Hematopoietic stem cell transplantation |
| concepts[4].id | https://openalex.org/C28328180 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5577418208122253 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q48196 |
| concepts[4].display_name | Stem cell |
| concepts[5].id | https://openalex.org/C2779972918 |
| concepts[5].level | 3 |
| concepts[5].score | 0.5518381595611572 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q1194520 |
| concepts[5].display_name | Graft-versus-host disease |
| concepts[6].id | https://openalex.org/C2777761686 |
| concepts[6].level | 2 |
| concepts[6].score | 0.5069118142127991 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q715347 |
| concepts[6].display_name | Lymphocyte |
| concepts[7].id | https://openalex.org/C90924648 |
| concepts[7].level | 1 |
| concepts[7].score | 0.45753151178359985 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q120569 |
| concepts[7].display_name | Gastroenterology |
| concepts[8].id | https://openalex.org/C197934379 |
| concepts[8].level | 2 |
| concepts[8].score | 0.44108396768569946 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q2047938 |
| concepts[8].display_name | Adverse effect |
| concepts[9].id | https://openalex.org/C126322002 |
| concepts[9].level | 1 |
| concepts[9].score | 0.42867758870124817 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[9].display_name | Internal medicine |
| concepts[10].id | https://openalex.org/C203014093 |
| concepts[10].level | 1 |
| concepts[10].score | 0.416853666305542 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[10].display_name | Immunology |
| concepts[11].id | https://openalex.org/C54355233 |
| concepts[11].level | 1 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[11].display_name | Genetics |
| concepts[12].id | https://openalex.org/C86803240 |
| concepts[12].level | 0 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[12].display_name | Biology |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9186566472053528 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/donor-lymphocyte-infusion |
| keywords[1].score | 0.7625124454498291 |
| keywords[1].display_name | Donor lymphocyte infusion |
| keywords[2].id | https://openalex.org/keywords/transplantation |
| keywords[2].score | 0.5919383764266968 |
| keywords[2].display_name | Transplantation |
| keywords[3].id | https://openalex.org/keywords/hematopoietic-stem-cell-transplantation |
| keywords[3].score | 0.5686824917793274 |
| keywords[3].display_name | Hematopoietic stem cell transplantation |
| keywords[4].id | https://openalex.org/keywords/stem-cell |
| keywords[4].score | 0.5577418208122253 |
| keywords[4].display_name | Stem cell |
| keywords[5].id | https://openalex.org/keywords/graft-versus-host-disease |
| keywords[5].score | 0.5518381595611572 |
| keywords[5].display_name | Graft-versus-host disease |
| keywords[6].id | https://openalex.org/keywords/lymphocyte |
| keywords[6].score | 0.5069118142127991 |
| keywords[6].display_name | Lymphocyte |
| keywords[7].id | https://openalex.org/keywords/gastroenterology |
| keywords[7].score | 0.45753151178359985 |
| keywords[7].display_name | Gastroenterology |
| keywords[8].id | https://openalex.org/keywords/adverse-effect |
| keywords[8].score | 0.44108396768569946 |
| keywords[8].display_name | Adverse effect |
| keywords[9].id | https://openalex.org/keywords/internal-medicine |
| keywords[9].score | 0.42867758870124817 |
| keywords[9].display_name | Internal medicine |
| keywords[10].id | https://openalex.org/keywords/immunology |
| keywords[10].score | 0.416853666305542 |
| keywords[10].display_name | Immunology |
| language | en |
| locations[0].id | doi:10.1038/s41409-020-0991-5 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S183182149 |
| locations[0].source.issn | 0268-3369, 1476-5365 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0268-3369 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Bone Marrow Transplantation |
| locations[0].source.host_organization | https://openalex.org/P4310319965 |
| locations[0].source.host_organization_name | Springer Nature |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319965 |
| locations[0].source.host_organization_lineage_names | Springer Nature |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Bone Marrow Transplantation |
| locations[0].landing_page_url | https://doi.org/10.1038/s41409-020-0991-5 |
| locations[1].id | pmid:32624583 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Bone marrow transplantation |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/32624583 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:10805111 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Bone Marrow Transplant |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10805111 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5050918879 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-0768-0331 |
| authorships[0].author.display_name | Ko Ko Maung |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210126298 |
| authorships[0].affiliations[0].raw_affiliation_string | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[0].institutions[0].id | https://openalex.org/I4210126298 |
| authorships[0].institutions[0].ror | https://ror.org/03njmea73 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210126298, https://openalex.org/I4210144876 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Duke Medical Center |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Ko K. Maung |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[1].author.id | https://openalex.org/A5010752724 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-4588-3890 |
| authorships[1].author.display_name | Benny J. Chen |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210126298 |
| authorships[1].affiliations[0].raw_affiliation_string | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[1].institutions[0].id | https://openalex.org/I4210126298 |
| authorships[1].institutions[0].ror | https://ror.org/03njmea73 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210126298, https://openalex.org/I4210144876 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Duke Medical Center |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Benny J. Chen |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[2].author.id | https://openalex.org/A5043348550 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Ian Barak |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210126298 |
| authorships[2].affiliations[0].raw_affiliation_string | Cancer Center Biostatistics, Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA |
| authorships[2].institutions[0].id | https://openalex.org/I4210126298 |
| authorships[2].institutions[0].ror | https://ror.org/03njmea73 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210126298, https://openalex.org/I4210144876 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Duke Medical Center |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Ian Barak |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Cancer Center Biostatistics, Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA |
| authorships[3].author.id | https://openalex.org/A5100437413 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-6869-2766 |
| authorships[3].author.display_name | Zhiguo Li |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210126298 |
| authorships[3].affiliations[0].raw_affiliation_string | Cancer Center Biostatistics, Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA |
| authorships[3].institutions[0].id | https://openalex.org/I4210126298 |
| authorships[3].institutions[0].ror | https://ror.org/03njmea73 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210126298, https://openalex.org/I4210144876 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Duke Medical Center |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Zhiguo Li |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Cancer Center Biostatistics, Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA |
| authorships[4].author.id | https://openalex.org/A5061865992 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-9886-5771 |
| authorships[4].author.display_name | David A. Rizzieri |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210126298 |
| authorships[4].affiliations[0].raw_affiliation_string | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[4].institutions[0].id | https://openalex.org/I4210126298 |
| authorships[4].institutions[0].ror | https://ror.org/03njmea73 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210126298, https://openalex.org/I4210144876 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Duke Medical Center |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | David A. Rizzieri |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[5].author.id | https://openalex.org/A5033550793 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-1513-5605 |
| authorships[5].author.display_name | Cristina Gasparetto |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210126298 |
| authorships[5].affiliations[0].raw_affiliation_string | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[5].institutions[0].id | https://openalex.org/I4210126298 |
| authorships[5].institutions[0].ror | https://ror.org/03njmea73 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210126298, https://openalex.org/I4210144876 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Duke Medical Center |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Cristina Gasparetto |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[6].author.id | https://openalex.org/A5037247107 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-1379-9216 |
| authorships[6].author.display_name | Keith M. Sullivan |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210126298 |
| authorships[6].affiliations[0].raw_affiliation_string | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[6].institutions[0].id | https://openalex.org/I4210126298 |
| authorships[6].institutions[0].ror | https://ror.org/03njmea73 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210126298, https://openalex.org/I4210144876 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Duke Medical Center |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Keith M. Sullivan |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[7].author.id | https://openalex.org/A5112929069 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Gwynn D. Long |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210126298 |
| authorships[7].affiliations[0].raw_affiliation_string | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[7].institutions[0].id | https://openalex.org/I4210126298 |
| authorships[7].institutions[0].ror | https://ror.org/03njmea73 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210126298, https://openalex.org/I4210144876 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | Duke Medical Center |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Gwynn D. Long |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[8].author.id | https://openalex.org/A5056043806 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-5118-1193 |
| authorships[8].author.display_name | Ashley Morris Engemann |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210126298 |
| authorships[8].affiliations[0].raw_affiliation_string | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[8].institutions[0].id | https://openalex.org/I4210126298 |
| authorships[8].institutions[0].ror | https://ror.org/03njmea73 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210126298, https://openalex.org/I4210144876 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | Duke Medical Center |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Ashley M. Engemann |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[9].author.id | https://openalex.org/A5005609746 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Barbara Waters‐Pick |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210126298 |
| authorships[9].affiliations[0].raw_affiliation_string | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[9].institutions[0].id | https://openalex.org/I4210126298 |
| authorships[9].institutions[0].ror | https://ror.org/03njmea73 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210126298, https://openalex.org/I4210144876 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | Duke Medical Center |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Barbara Waters-Pick |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[10].author.id | https://openalex.org/A5079404106 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-2722-8972 |
| authorships[10].author.display_name | Krista Rowe Nichols |
| authorships[10].countries | US |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210126298 |
| authorships[10].affiliations[0].raw_affiliation_string | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[10].institutions[0].id | https://openalex.org/I4210126298 |
| authorships[10].institutions[0].ror | https://ror.org/03njmea73 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210126298, https://openalex.org/I4210144876 |
| authorships[10].institutions[0].country_code | US |
| authorships[10].institutions[0].display_name | Duke Medical Center |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Krista Rowe Nichols |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[11].author.id | https://openalex.org/A5049930588 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Richard D. Lopez |
| authorships[11].countries | US |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210126298 |
| authorships[11].affiliations[0].raw_affiliation_string | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[11].institutions[0].id | https://openalex.org/I4210126298 |
| authorships[11].institutions[0].ror | https://ror.org/03njmea73 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210126298, https://openalex.org/I4210144876 |
| authorships[11].institutions[0].country_code | US |
| authorships[11].institutions[0].display_name | Duke Medical Center |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Richard Lopez |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[12].author.id | https://openalex.org/A5008453908 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-6678-8732 |
| authorships[12].author.display_name | Yubin Kang |
| authorships[12].countries | US |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210126298 |
| authorships[12].affiliations[0].raw_affiliation_string | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[12].institutions[0].id | https://openalex.org/I4210126298 |
| authorships[12].institutions[0].ror | https://ror.org/03njmea73 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210126298, https://openalex.org/I4210144876 |
| authorships[12].institutions[0].country_code | US |
| authorships[12].institutions[0].display_name | Duke Medical Center |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Yubin Kang |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[13].author.id | https://openalex.org/A5077581687 |
| authorships[13].author.orcid | https://orcid.org/0000-0003-4551-6687 |
| authorships[13].author.display_name | Stefanie Sarantopoulos |
| authorships[13].countries | US |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210126298 |
| authorships[13].affiliations[0].raw_affiliation_string | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[13].institutions[0].id | https://openalex.org/I4210126298 |
| authorships[13].institutions[0].ror | https://ror.org/03njmea73 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I4210126298, https://openalex.org/I4210144876 |
| authorships[13].institutions[0].country_code | US |
| authorships[13].institutions[0].display_name | Duke Medical Center |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Stefanie Sarantopoulos |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[14].author.id | https://openalex.org/A5063907259 |
| authorships[14].author.orcid | https://orcid.org/0000-0003-3765-641X |
| authorships[14].author.display_name | Anthony D. Sung |
| authorships[14].countries | US |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I4210126298 |
| authorships[14].affiliations[0].raw_affiliation_string | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[14].institutions[0].id | https://openalex.org/I4210126298 |
| authorships[14].institutions[0].ror | https://ror.org/03njmea73 |
| authorships[14].institutions[0].type | healthcare |
| authorships[14].institutions[0].lineage | https://openalex.org/I4210126298, https://openalex.org/I4210144876 |
| authorships[14].institutions[0].country_code | US |
| authorships[14].institutions[0].display_name | Duke Medical Center |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Anthony D. Sung |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[15].author.id | https://openalex.org/A5034651124 |
| authorships[15].author.orcid | https://orcid.org/0000-0001-6725-7220 |
| authorships[15].author.display_name | Nelson J. Chao |
| authorships[15].countries | US |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I4210126298 |
| authorships[15].affiliations[0].raw_affiliation_string | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[15].institutions[0].id | https://openalex.org/I4210126298 |
| authorships[15].institutions[0].ror | https://ror.org/03njmea73 |
| authorships[15].institutions[0].type | healthcare |
| authorships[15].institutions[0].lineage | https://openalex.org/I4210126298, https://openalex.org/I4210144876 |
| authorships[15].institutions[0].country_code | US |
| authorships[15].institutions[0].display_name | Duke Medical Center |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Nelson J. Chao |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[16].author.id | https://openalex.org/A5018922885 |
| authorships[16].author.orcid | https://orcid.org/0000-0001-9863-8464 |
| authorships[16].author.display_name | Mitchell E. Horwitz |
| authorships[16].countries | US |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I4210126298 |
| authorships[16].affiliations[0].raw_affiliation_string | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| authorships[16].institutions[0].id | https://openalex.org/I4210126298 |
| authorships[16].institutions[0].ror | https://ror.org/03njmea73 |
| authorships[16].institutions[0].type | healthcare |
| authorships[16].institutions[0].lineage | https://openalex.org/I4210126298, https://openalex.org/I4210144876 |
| authorships[16].institutions[0].country_code | US |
| authorships[16].institutions[0].display_name | Duke Medical Center |
| authorships[16].author_position | last |
| authorships[16].raw_author_name | Mitchell E. Horwitz |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC, USA |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10805111 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10345 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2720 |
| primary_topic.subfield.display_name | Hematology |
| primary_topic.display_name | Hematopoietic Stem Cell Transplantation |
| related_works | https://openalex.org/W4210539530, https://openalex.org/W2302449393, https://openalex.org/W3168611530, https://openalex.org/W2126499965, https://openalex.org/W187678363, https://openalex.org/W2916618455, https://openalex.org/W2044696250, https://openalex.org/W2330827888, https://openalex.org/W1997956599, https://openalex.org/W2411639363 |
| cited_by_count | 27 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 2 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 6 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 9 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 5 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 4 |
| counts_by_year[5].year | 2020 |
| counts_by_year[5].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | pmh:oai:pubmedcentral.nih.gov:10805111 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764455111 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | PubMed Central |
| best_oa_location.source.host_organization | https://openalex.org/I1299303238 |
| best_oa_location.source.host_organization_name | National Institutes of Health |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Text |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | Bone Marrow Transplant |
| best_oa_location.landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10805111 |
| primary_location.id | doi:10.1038/s41409-020-0991-5 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S183182149 |
| primary_location.source.issn | 0268-3369, 1476-5365 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0268-3369 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Bone Marrow Transplantation |
| primary_location.source.host_organization | https://openalex.org/P4310319965 |
| primary_location.source.host_organization_name | Springer Nature |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319965 |
| primary_location.source.host_organization_lineage_names | Springer Nature |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Bone Marrow Transplantation |
| primary_location.landing_page_url | https://doi.org/10.1038/s41409-020-0991-5 |
| publication_date | 2020-07-05 |
| publication_year | 2020 |
| referenced_works | https://openalex.org/W2590030902, https://openalex.org/W2013235252, https://openalex.org/W1988779573, https://openalex.org/W2033477706, https://openalex.org/W2068699102, https://openalex.org/W1988718803, https://openalex.org/W2034877897, https://openalex.org/W2110255986, https://openalex.org/W2794388964, https://openalex.org/W2053278212, https://openalex.org/W2379365975, https://openalex.org/W2017908149, https://openalex.org/W1603504083, https://openalex.org/W1913133353, https://openalex.org/W2769044088, https://openalex.org/W1975040998 |
| referenced_works_count | 16 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 17 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8299999833106995 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.9090796 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |